Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 3, 2009, Pages 428-435

  Lemesle, Gilles ^a   De Labriolle, Axel ^a   Bonello, Laurent ^a   Syed, Asmir ^a   Collins, Sara ^a   Maluenda, Gabriel ^a   Torguson, Rebecca ^a   Kaneshige, Kimberly ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Bivalirudin; Octogenarians; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CLOPIDOGREL; CREATININE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; ANTICOAGULANT AGENT; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; BODY MASS; CARDIOGENIC SHOCK; CHRONIC KIDNEY FAILURE; CIGARETTE SMOKING; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; ELDERLY CARE; FAMILY HISTORY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOCRIT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE HEMORRHAGE; SCORING SYSTEM; SEX DIFFERENCE; STABLE ANGINA PECTORIS; THROMBOCYTE COUNT; TREATMENT INDICATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; AGE; ANGIOCARDIOGRAPHY; BLEEDING; COMPARATIVE STUDY; INSTRUMENTATION; KAPLAN MEIER METHOD; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGE FACTORS; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEMORRHAGE; HEPARIN; HIRUDINS; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; PATIENT SELECTION; PEPTIDE FRAGMENTS; PROPORTIONAL HAZARDS MODELS; RECOMBINANT PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350501480     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22007     Document Type: Article

References (26)

1. Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew DP, Bittl JA, Topol EJ, Manoukian SV. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007;100:1364-1369. (Pubitemid 47576015)
2. Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, Gevorkian N, Pinnow EE, Kent KM, Pichard AD, Satler LF, Weissman NJ, Lindsay J, Fuchs S. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-935. (Pubitemid 37214804)
3. Voeltz MD, Patel AD, Feit F, Fazel R, Lincoff AM, Manoukian SV. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 2007;99:1513-1517. (Pubitemid 46770636)
4. Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, Slater J. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart. Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2007;69:961-966.
5. Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EM;TRITON-TIMI, 38 Investigators. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: A subanalysis of a randomised trial. Lancet 2008;371:1353-1363.
6. Wiviott SD, Braunwald E, Murphy SA, Antman EM. A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38. Am J Cardiol 2008;101:1367-1370.
7. Kastrati A, Neumann FJ, Mehilli J, Byrne RA, Iijima R, Büttner HJ, Khattab AA, Schulz S, Blankenship JC, Pache J, Minners J, Seyfarth M, Graf I, Skelding KA, Dirschinger J, Richardt G, Berger PB, Schömig A;ISAR-REACT, 3 Trial Investigators. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 2008;359:688-696.
8. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, King SB 3rd, Ohman EM, Stone GW. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY Trial. J Am Coll Cardiol 2007;49:1362-1368. (Pubitemid 46476844)
9. Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW;Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial investigators. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 2007;369:907-919.
10. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R;HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-2230.
11. TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): A randomised trial. Lancet 2001;358:951-957.
12. Assali AR, Moustapha A, Sdringola S, Salloum J, Awadalla H, Saikia S, Ghani M, Hale S, Schroth G, Rosales O, Anderson HV, Smalling RW. The dilemma of success: Percutaneous coronary interventions in patients [mtequ]75 years of age-successful but associated with higher vascular complications and cardiac mortality. Catheter Cardiovasc Interv 2003;59:195-199. (Pubitemid 36665950)
13. Batchelor WB, Anstrom KJ, Muhlbaier LH, Grosswald R, Weintraub WS, O'Neill WW, Peterson ED. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol 2000;36:723-730.
14. Bauer T, Koeth O, Junger C, Heer T, Wienbergen H, Gitt A, Zahn R, Senges J, Zeymer U. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. Eur Heart J 2007;28:2873-2878. (Pubitemid 350233033)
15. Dacey LJ, Likosky DS, Ryan TJ Jr, Robb JF, Quinn RD, DeVries JT, Hearne MJ, Leavitt BJ, Dunton RF, Clough RA, Sisto D, Ross CS, Olmstead EM, O'Connor GT, Malenka DJ;Northern New England Cardiovascular Disease Study Group. Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease. Ann Thorac Surg 2007;84:1904-1911.
16. Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC, Minutello RM. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry). Am J Cardiol 2006;98:1334-1339.
17. Hassani SE, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R. Percutaneous coronary intervention with drug-eluting stents in octogenarians: Characteristics, clinical presentation, and outcomes. Catheter Cardiovasc Interv 2006;68:36-43. (Pubitemid 44024459)
18. Kobayashi Y, Mehran R, Mintz GS, Dangas G, Moussa I, Lansky AJ, Stone GW, Moses JW, Leon MB. Comparison of inhospital and one-year outcomes after multiple coronary arterial stenting in patients [mtequ]80 years old versus those <80 years old. Am J Cardiol 2003;92:443-446. (Pubitemid 36959882)
19. Little T, Milner MR, Lee K, Constantine J, Pichard AD, Lindsay J Jr. Late outcome and quality of life following percutaneous transluminal coronary angioplasty in octogenarians. Cathet Cardiovasc Diagn 1993;29:261-266. (Pubitemid 23219004)
20. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: Four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation 2004;110:1213-1218. (Pubitemid 39202335)
21. Vlaar PJ, Lennon RJ, Rihal CS, Singh M, Ting HH, Bresnahan JF, Holmes DR Jr. Drug-eluting stents in octogenarians: Early and intermediate outcome. Am Heart J 2008;155:680-686.
22. Weintraub WS, Veledar E, Thompson T, Burnette J, Jurkovitz C, Mahoney E. Percutaneous coronary intervention outcomes in octogenarians during the stent era (National Cardiovascular Network). Am J Cardiol 2001;88:1407-1410, A6. (Pubitemid 34008684)
23. Wenaweser P, Ramser M, Windecker S, Lutolf I, Meier B, Seiler C, Eberli FR, Hess OM. Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2007;70:485-490. (Pubitemid 47597015)
24. Yan BP, Gurvitch R, Duffy SJ, Clark DJ, Sebastian M, New G, Warren R, Lefkovits J, Lew R, Brennan AL, Reid C, Andrianopoulos N, Ajani AE. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry. Catheter Cardiovasc Interv 2007;70:928-936.
25. Mehran R, Brodie B, Cox DA, Grines CL, Rutherford B, Bhatt DL, Dangas G, Feit F, Ohman EM, Parise H, Fahy M, Lansky AJ, Stone GW. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale. Am Heart J 2008;156:44-56. (Pubitemid 351862292)
26. Steinberg DH, Shah P, Kinnaird T, Pinto Slottow TL, Roy PK, Okabe T, Bonello L, de Labriolle A, Smith KA, Torguson R, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R. Bleeding risk and outcomes of bivalirudin versus glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Am J Cardiol 2008;102:160-164.